About Pohl-Boskamp
Pohl-Boskamp is a Healthcare company founded in 1835. Pharmaceutical drugs are developed by Pohl-Boskamp in the healthcare sector. Pohl-Boskamp has completed 2 acquisitions, including Kalmeda and MyNoise. Its website pohl-boskamp.de draws about 40 thousand monthly visits. Pohl-Boskamp offers products and services including ELOM-080 and Kalmeda Tinnitus-App. Its focus areas include Traditional Pharmaceuticals. Its legal entity is G. Pohl-Boskamp GmbH & Co. KG.
Company details
Pohl-Boskamp was established in 1835 as a pharmaceutical entity focused on drug development. Operations are centered on creating and manufacturing medicinal products for various therapeutic areas. The company is headquartered in Germany, where research and production activities are conducted. Services include formulation and distribution of pharmaceuticals, supporting healthcare needs across domestic and international markets. No specific location details beyond the national base are provided.
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website pohl-boskamp.de
- Social LinkedIn YouTube
- Legal Name G. Pohl-Boskamp Gmbh & Co. Kg
- Latest Funding Round$1.04M (USD), Grant
Jun 2022
- Investors
- Investments & AcquisitionsKalmeda
& 1 more
Products & Services of Pohl-Boskamp
Pohl-Boskamp offers a comprehensive portfolio of products and services, including ELOM-080 and Kalmeda Tinnitus-App.
This medicine is used for treating respiratory conditions and was evaluated in clinical trials
This app is utilized for managing tinnitus and has been secured through company acquisitions
Apps and channels of Pohl-Boskamp
its YouTube channel PohlBoskampTV has 1.27K subscribers and 30 videos.
Videos from Pohl-Boskamp
The most watched videos on Pohl-Boskamp's YouTube channel, PohlBoskampTV (1.27K subscribers). Click a video to play it here.
More on PohlBoskampTV.
Funding Insights of Pohl-Boskamp
- Total Rounds 2
- Last Round Grant — $1.04M
- First Round $8.95M
(Dec 2021)
- Investors Count 1
All 2 funding rounds of Pohl-Boskamp with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2022 | $1.04M | Grant | – | – | |
| Dec 2021 | $8.95M | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Pohl-Boskamp
Pohl-Boskamp has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Pohl-Boskamp
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pohl-Boskamp
Pohl-Boskamp has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Kalmeda and MyNoise.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
App for tinnitus management | kalmeda.de | Duisburg, Germany | 2015 | May 2023 | •••• | |
Mobile app providing cognitive behavioral therapy for chronic Tinnitus management. | mynoise.de | Duisburg, Germany | 2013 | May 2023 | •••• |
Complete acquisition details for Pohl-Boskamp
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Pohl-Boskamp
Web traffic of Pohl-Boskamp
The website of Pohl-Boskamp (pohl-boskamp.de) receives about 40.4K visits a month and ranks #565,295 among all websites worldwide, #589 in Biotechnology and Pharmaceuticals.
- Monthly visits40.4K
▲ 27.2% vs previous month
- Unique visitors4.9K
per month
- Global rank#565,295
among all websites
- Category rank#589
Health · Biotechnology and Pharmaceuticals
- Bounce rate16%
- Pages per visit16.5
- Average visit19 min 45 sec
- DevicesDesktop 74% · Mobile 26%
Websites whose visitors overlap most with Pohl-Boskamp. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
mibe.de | mibe.de | 100% | – | ||
| engelhard.de | 98% | 10.9K | #1,332,804 | View details | |
bene-arzneimittel.de | bene-arzneimittel.de | 98% | #3,932,465 | – | |
heumann.de | heumann.de | 98% | #575,516 | – | |
eurim.de | eurim.de | 98% | #6,966,716 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 13 similar websites and full traffic analytics for Pohl-Boskamp
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Pohl-Boskamp
Pohl-Boskamp was founded in 1835 and raised its 1st funding round 186 years after it was founded.
Pohl-Boskamp was established in 1835 as a pharmaceutical entity focused on drug development. Operations are centered on creating and manufacturing medicinal products for various therapeutic areas. The company is headquartered in Germany, where research and production activities are conducted. Services include formulation and distribution of pharmaceuticals, supporting healthcare needs across domestic and international markets. No specific location details beyond the national base are provided.
Pohl-Boskamp offers ELOM-080 and Kalmeda Tinnitus-App.
Pohl-Boskamp has 1 investor. Key investors include European Union.
Pohl-Boskamp operates through G. Pohl-Boskamp Gmbh & Co. Kg.